HDAC 6/8 inhibitors (Roche)

N/A

Report date: 2025/01/15 20:00:32
NME

Base Information

Drug NameHDAC 6/8 inhibitors (Roche)
Drug Alias NameHDAC 6/8 inhibitors (cancer), Roche
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 6 inhibitorsHistone deacetylase 8 inhibitors
TargetsHistone deacetylase 8Histone deacetylase 6
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesRoche Holding Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoche Holding Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A